Gibson, Dunn & Crutcher LLP has advised KKR and NetSPI. Latham & Watkins LLP has advised Synack. NetSPI, a global leader in modern penetration testing, and...
NetSPI and Synack Announce Merger to Form Leading Offensive Cybersecurity Platform
Nielsen Acquires DoubleVerify for $2.15 Billion
Gibson Dunn has advised Nielsen Holdings. Paul Hastings LLP has advised DoubleVerify. Davis Polk & Wardwell LLP has advised Providence Equity Partners LLC and its affiliated...
J.P. Morgan Private Capital Participates in $700 Million Funding Round for Lumilens
Gibson Dunn has advised J.P. Morgan Private Capital on the transaction. Lumilens, a leading connectivity platform for AI infrastructure, completed a new financing round exceeding $700...
Tower Arch Capital Recapitalizes Boxzooka eFulfillment in Partnership with Management
Gibson Dunn, Grant Thornton, West Monroe, and Lockton have advised Tower Arch Capital. SDR Ventures, Taft Law, and Curran & Company, LLP have advised Boxzooka eFulfillment....
SSW Partners Acquires Delivery Hero Operations in 14 Markets for $1.6 Billion
Hengeler Mueller, Paul, Weiss, Rifkind, Wharton & Garrison, Baker Botts, and Gibson Dunn have advised SSW Partners on the acquisition of Delivery Hero’s businesses in 14...
CRH Announces $8.5 Billion Acquisition of Arcosa
Kirkland & Ellis and Linklaters have advised CRH. Gibson Dunn and Baker Botts have advised Arcosa. CRH (NYSE: CRH), a leading provider of building materials, has...
CoStar Group to Acquire Zonda from MidOcean Partners
Latham & Watkins has advised CoStar Group, Inc. Gibson Dunn has advised MidOcean Partners. CoStar Group, Inc. has signed a definitive agreement to acquire Zonda, the...
Databricks Closes Over $4 Billion Series L Funding Round at $134 Billion Valuation
Fenwick & West has advised Databricks. Gibson Dunn has advised J.P. Morgan Asset Management as co-lead investor. Kirkland & Ellis has advised Blackstone. Databricks has completed...
Denali Therapeutics Enters $275 Million Synthetic Royalty Funding Agreement with Royalty Pharma
Gibson Dunn has advised Denali Therapeutics. Goodwin Procter and Maiwald have advised Royalty Pharma. Denali Therapeutics Inc. (Nasdaq: DNL) and Royalty Pharma plc (Nasdaq: RPRX) have...
Galecto Acquires Damora Therapeutics and Secures $285 Million PIPE Investment
Cleary Gottlieb has advised Viking Global Investors. Gibson Dunn has advised Damora Therapeutics. The acquisition of Damora Therapeutics Inc. by Galecto Inc. was completed alongside a...
Ultragenyx Sells Portion of Future Crysvita Royalties to OMERS for $400 Million
Gibson, Dunn & Crutcher LLP has advised Ultragenyx Pharmaceutical Inc. Davies Ward Phillips & Vineberg LLP, Latham & Watkins LLP, and Sidley Austin LLP have advised...
XOMA Royalty Corporation Establishes $50 Million At-the-Market Facility
Gibson Dunn has advised XOMA Royalty Corporation, and Duane Morris has advised H.C. Wainwright & Co., LLC. XOMA Royalty Corporation has established an at-the-market facility allowing...